Diese Seite wurde automatisch übersetzt und die Genauigkeit der Übersetzung wird nicht garantiert. Bitte wende dich an die englische Version für einen Quelltext.

AI-Assisted Camera-Based Progressive Muscle Relaxation for Office Workers (AI-PMR)

17. Mai 2026 aktualisiert von: dogukan kurc, Istanbul Medipol University Hospital

Effectiveness of an AI-Assisted Camera-Based Progressive Muscle Relaxation Application in Office Workers: A Randomized Controlled Trial

This randomized controlled trial evaluates the effectiveness of an AI-assisted, camera-based progressive muscle relaxation application in office workers aged 20 to 40 years. Participants are randomly allocated to an intervention group or a control group. The intervention group completes a 4-week progressive muscle relaxation program using the PhysioTR Academic application, which provides camera-based real-time movement analysis and exercise guidance. The control group continues their usual daily routine and completes baseline and post-intervention assessments only. Outcomes include pain/tension intensity, musculoskeletal symptoms, perceived stress, neck disability, work productivity, functionality, and AI-based adherence metrics.

Studienübersicht

Detaillierte Beschreibung

This study is a single-center, randomized, controlled, open-label trial conducted in office workers aged 20 to 40 years. Participants are automatically randomized into either an intervention group or a control group.

The intervention group uses the PhysioTR Academic application for a 4-week progressive muscle relaxation program. The program includes 3 sessions per week, 12 sessions in total. Each session includes four exercise components: face and jaw, neck and shoulders, hands and arms, and back and chest. Each exercise includes a contraction and relaxation phase. The application uses the participant's device camera for real-time movement analysis and provides written and/or audio guidance.

The control group continues their usual daily routine and does not receive an exercise intervention during the study period. The control group completes only baseline and post-intervention assessments.

Assessments are performed at baseline and Week 4. Outcome measures include the Visual Analog Scale, Nordic Musculoskeletal Questionnaire, Perceived Stress Scale, Neck Disability Index, Work Productivity Scale, numeric functionality score, and AI-based adherence and landmark coverage metrics in the intervention group.

Studientyp

Interventionell

Einschreibung (Tatsächlich)

60

Phase

  • Unzutreffend

Kontakte und Standorte

Dieser Abschnitt enthält die Kontaktdaten derjenigen, die die Studie durchführen, und Informationen darüber, wo diese Studie durchgeführt wird.

Studienorte

    • Beykoz
      • Istanbul, Beykoz, Türkei (türkiye), 34810
        • Istanbul Medipol University, Faculty of Health Sciences, Department of Physiotherapy and Rehabilitation

Teilnahmekriterien

Forscher suchen nach Personen, die einer bestimmten Beschreibung entsprechen, die als Auswahlkriterien bezeichnet werden. Einige Beispiele für diese Kriterien sind der allgemeine Gesundheitszustand einer Person oder frühere Behandlungen.

Zulassungskriterien

Studienberechtigtes Alter

  • Erwachsene

Akzeptiert gesunde Freiwillige

Ja

Beschreibung

Inclusion Criteria:

  • Aged between 20 and 40 years
  • Actively working in a desk-based or office-based job
  • Having access to a camera-enabled device such as a smartphone or computer
  • Voluntary participation with informed consent
  • Able to read and write Turkish
  • Having a valid e-mail address

Exclusion Criteria:

  • Previous surgery involving the neck or spine
  • Cervical vertebral fracture or instability
  • History of neurological disease such as multiple sclerosis or Parkinson's disease
  • Vestibular system disorder
  • Systemic inflammatory disease such as rheumatoid arthritis or ankylosing spondylitis
  • History of malignancy
  • Pregnancy
  • Having received physiotherapy for the neck or back region within the last 6 months

Studienplan

Dieser Abschnitt enthält Einzelheiten zum Studienplan, einschließlich des Studiendesigns und der Messung der Studieninhalte.

Wie ist die Studie aufgebaut?

Designdetails

  • Hauptzweck: Unterstützende Pflege
  • Zuteilung: Zufällig
  • Interventionsmodell: Parallele Zuordnung
  • Maskierung: Keine (Offenes Etikett)

Waffen und Interventionen

Teilnehmergruppe / Arm
Intervention / Behandlung
Experimental: AI-Assisted Camera-Based Progressive Muscle Relaxation Group
Participants in this group complete a 4-week progressive muscle relaxation program using the PhysioTR Academic application. The program includes 3 sessions per week, 12 sessions in total. Each session includes four components: face and jaw, neck and shoulders, hands and arms, and back and chest. The application uses the participant's device camera for real-time movement analysis and records session-level Visual Analog Scale scores and AI-based adherence metrics.
A camera-based progressive muscle relaxation program delivered through the PhysioTR Academic web application. The intervention includes 4 weeks of training, 3 sessions per week, for a total of 12 sessions. The application provides written and/or audio instructions and uses camera-based real-time movement analysis to support exercise performance and adherence monitoring.
Kein Eingriff: Control Group
Participants in the control group continue their usual daily routine and do not receive an exercise intervention during the study period. They complete baseline and Week 4 assessments only.

Was misst die Studie?

Primäre Ergebnismessungen

Ergebnis Maßnahme
Maßnahmenbeschreibung
Zeitfenster
Change in Pain/Tension Intensity Assessed by Visual Analog Scale
Zeitfenster: Baseline and Week 4
Pain/tension intensity is assessed using a 0-10 Visual Analog Scale. Higher scores indicate greater pain/tension intensity. Change is calculated from baseline to Week 4.
Baseline and Week 4

Sekundäre Ergebnismessungen

Ergebnis Maßnahme
Maßnahmenbeschreibung
Zeitfenster
Change in Musculoskeletal Symptoms Assessed by the Nordic Musculoskeletal Questionnaire
Zeitfenster: Baseline and Week 4
Musculoskeletal symptoms are assessed using the Nordic Musculoskeletal Questionnaire across body regions. The outcome is summarized as the presence of symptoms by region and/or the number of symptomatic body regions. Higher values indicate more widespread musculoskeletal symptoms.
Baseline and Week 4
Change in Perceived Stress Scale Score
Zeitfenster: Baseline and Week 4
Perceived stress is assessed using the Turkish version of the Perceived Stress Scale. Higher scores indicate greater perceived stress.
Baseline and Week 4
Change in Neck Disability Index Score
Zeitfenster: Baseline and Week 4
Neck-related disability is assessed using the Neck Disability Index. Higher scores indicate greater neck-related disability.
Baseline and Week 4
Change in Work Productivity Scale Score
Zeitfenster: Baseline and Week 4
Work productivity is assessed using a 5-item Likert-type Work Productivity Scale. Total scores range from 5 to 25, with higher scores indicating higher work productivity.
Baseline and Week 4
Change in Numeric Functionality Score
Zeitfenster: Baseline and Week 4
General functionality is assessed using a numeric rating scale from 0 to 10, where 0 indicates very poor functionality and 10 indicates excellent functionality. Higher scores indicate better functionality.
Baseline and Week 4
AI-Based Exercise Adherence Score
Zeitfenster: During each of the 12 sessions over the 4-week intervention period
In the intervention group, the application automatically calculates an AI-based adherence score as the percentage of predefined exercise criteria met during each session. Scores range from 0 to 100%, with higher scores indicating better adherence to the required exercise form.
During each of the 12 sessions over the 4-week intervention period
AI-Based Landmark Coverage Ratio
Zeitfenster: During each of the 12 sessions over the 4-week intervention period
In the intervention group, the application calculates a landmark coverage ratio as the percentage of required body landmarks detected by the camera during each exercise. Scores range from 0 to 100%, with higher scores indicating better camera-based landmark detection.
During each of the 12 sessions over the 4-week intervention period

Andere Ergebnismessungen

Ergebnis Maßnahme
Maßnahmenbeschreibung
Zeitfenster
Immediate Change in Session-Level Pain/Tension Intensity
Zeitfenster: Immediately before and after each session during the 4-week intervention period
In the intervention group, pain/tension intensity is recorded immediately before and after each progressive muscle relaxation session using a 0-10 Visual Analog Scale. The immediate session-level change is calculated as post-session score minus pre-session score.
Immediately before and after each session during the 4-week intervention period

Mitarbeiter und Ermittler

Hier finden Sie Personen und Organisationen, die an dieser Studie beteiligt sind.

Studienaufzeichnungsdaten

Diese Daten verfolgen den Fortschritt der Übermittlung von Studienaufzeichnungen und zusammenfassenden Ergebnissen an ClinicalTrials.gov. Studienaufzeichnungen und gemeldete Ergebnisse werden von der National Library of Medicine (NLM) überprüft, um sicherzustellen, dass sie bestimmten Qualitätskontrollstandards entsprechen, bevor sie auf der öffentlichen Website veröffentlicht werden.

Haupttermine studieren

Studienbeginn (Tatsächlich)

8. April 2026

Primärer Abschluss (Tatsächlich)

13. Mai 2026

Studienabschluss (Tatsächlich)

13. Mai 2026

Studienanmeldedaten

Zuerst eingereicht

30. April 2026

Zuerst eingereicht, das die QC-Kriterien erfüllt hat

30. April 2026

Zuerst gepostet (Tatsächlich)

7. Mai 2026

Studienaufzeichnungsaktualisierungen

Letztes Update gepostet (Tatsächlich)

20. Mai 2026

Letztes eingereichtes Update, das die QC-Kriterien erfüllt

17. Mai 2026

Zuletzt verifiziert

1. Mai 2026

Mehr Informationen

Begriffe im Zusammenhang mit dieser Studie

Plan für individuelle Teilnehmerdaten (IPD)

Planen Sie, individuelle Teilnehmerdaten (IPD) zu teilen?

NEIN

Beschreibung des IPD-Plans

Individual participant data will not be publicly shared due to ethical approval conditions and personal data protection requirements. De-identified aggregate data may be made available from the corresponding investigator upon reasonable request, subject to institutional and ethics approval.

Arzneimittel- und Geräteinformationen, Studienunterlagen

Studiert ein von der US-amerikanischen FDA reguliertes Arzneimittelprodukt

Nein

Studiert ein von der US-amerikanischen FDA reguliertes Geräteprodukt

Nein

Diese Informationen wurden ohne Änderungen direkt von der Website clinicaltrials.gov abgerufen. Wenn Sie Ihre Studiendaten ändern, entfernen oder aktualisieren möchten, wenden Sie sich bitte an register@clinicaltrials.gov. Sobald eine Änderung auf clinicaltrials.gov implementiert wird, wird diese automatisch auch auf unserer Website aktualisiert .

Abonnieren